PLASMACYTOMA

Clinical trials for PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new PLASMACYTOMA trials appear

Sign up with your email to follow new studies for PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

New drug cocktail targets Hard-to-Treat myeloma

Disease control Terminated

This early-phase trial tested a new drug called KRT-232 combined with three standard myeloma drugs (carfilzomib, lenalidomide, and dexamethasone) in 35 patients whose multiple myeloma had returned or stopped responding to treatment. The main goals were to check safety and find th…

Matched conditions: PLASMACYTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC

PLASMACYTOMA

Get alerted when new PLASMACYTOMA trials appear

New drug cocktail targets Hard-to-Treat myeloma